Scientists conducting medical research are facing an existential crisis: Layoffs and budget cuts pushed by President Trump ...

Knowing your family history and symptoms to watch for can help ensure the disease is diagnosed as soon as possible ...

A new survey from Takeda due to be presented at the ESMO Gastrointestinal Cancers Congress in Spain this week highlights ...

Cancer patients receiving immune checkpoint inhibitor (ICI) therapy may experience more severe toxicity and have a greater risk of death if they have recently used proton pump inhibitors (PPIs), ...

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

Dr. Breelyn Wilky, director of sarcoma medical oncology at the University of Colorado Cancer Center, encourages patients with gastrointestinal stromal tumors (GIST) to seek expert care and stay ...

NHS FDP Cancer 360 dominated the headlines last month as Government announced it is to be rolled out across the NHS. Initially piloted at Chelsea and Westminster NHS Foundation Trust’s gynaecology ...

BE is the only known precursor to esophageal cancer. The condition is caused by prolonged exposure of the esophagus to ...

Monotherapy efficacy and safety profile provided backbone for clinical development strategy in 1L combination with nivolumab ...

As early-onset cancer diagnoses surge among young people, doctors and researchers are urgently exploring potential causes ...

Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for ...

Recent advances in RAS-targeted therapies revolutionize treatment for gastrointestinal cancers, promising improved outcomes ...